E. Lebacq

Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants

Timo Vesikari, Aino Karvonen, Tiina Korhonen et al. · Vaccine · 2004 · 144 citations

Vaccination, Vaccine Safety, Vaccine Development +7

Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15–25 years

Lars Østergaard, E. Lebacq, Jan Poolman et al. · Vaccine · 2008 · 92 citations

Vaccinology, Vaccine Safety, Vaccination +10

Alternative Vaccination Schedules (0, 1, and 6 Months Versus 0, 1, and 12 Months) for a Recombinant OspA Lyme Disease Vaccine

Christian Van Hoecke, E. Lebacq, Jiřı́ Beran et al. · Clinical Infectious Diseases · 1999 · 55 citations · Full text

Healthy Subjects, Lyme Disease Vaccine, Immunodeficiencies +17

Fractionation of Human Leukocyte Extracts Transferring Delayed Hypersensitivity to Tuberculin

Mário Arala‐Chaves, E. Lebacq, J.F. Heremans · International Archives of Allergy and Immunology · 1967 · 40 citations

Clinical Immunology, Immunohematology, Laboratory Immunology +18

Comparative Tolerability and Immunogenicity of Typherix??? or Typhim Vi??? in Healthy Adults*

E. Lebacq · BioDrugs · 2001 · 34 citations

Vaccination, Primary Immunodeficiency, Autoimmune Disease +11